Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2011-07-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Balance Study
NCT05714150
Influence of Physical Exercise on Cognitive Functioning of Traumatic Brain Injury Patients
NCT01395472
Restoration of Life Role Participation Through Cognitive and Motor Training for TBI
NCT01158781
Efficacy of Multidimensional Management of Mild Traumatic Brain Injury
NCT03811626
Rehabilitation of Working Memory and Brain Plasticity After Traumatic Brain Injury: Plastim-MDTC
NCT03513133
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intensive Mobility Training (IMT)
Intensive Mobility Training will be used as an intensive physical therapy intervention. Participants will receive 3 hours per day for a 10 day session, be post-tested, and receive another 10 day session followed by two more testing sessions.
Intensive Mobility Training (IMT)
Intensive Mobility Training will be used as an intensive physical therapy intervention. Participants will receive 3 hours per day for a 10 day session, be post-tested, and receive another 10 day session followed by two more testing sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intensive Mobility Training (IMT)
Intensive Mobility Training will be used as an intensive physical therapy intervention. Participants will receive 3 hours per day for a 10 day session, be post-tested, and receive another 10 day session followed by two more testing sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. the ability to follow simple three-step commands;
3. the ability to communicate presence and location of pain;
4. the ability to sit independently without back or arm support for five minutes;
5. the ability to stand with support of a straight cane, quad cane, or walker for 2 minutes;
6. the ability to walk 10 meters with maximum 1 person assisting;
7. presence of motor deficits (determined by clinical assessment of paresis);
8. age ≥ 18;
9. ability to give consent or have a acceptable surrogate capable of giving consent on subject's behalf
Exclusion Criteria
2. history of serious chronic obstructive pulmonary disease or oxygen dependence;
3. severe weight bearing pain;
4. lower-extremity amputation;
5. non-healing ulcers on the lower-extremity;
6. renal dialysis or end stage liver disease;
7. legal blindness or severe visual impairment;
8. severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of -10°, knee flexion Range of Motion \< 90°, hip flexion contracture \> 25°, and ankle plantar flexion contracture \> 15°);
9. history of deep venous thrombosis or pulmonary embolism within 6 months
10. uncontrollable diabetes with recent weight loss, diabetic coma, or frequent insulin reactions;
11. severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110 mmHg at rest;
12. intracranial hemorrhage related to aneurysm rupture or an arteriovenous malformation (hemorrhagic infarctions will not be excluded);
13. history of severe uncontrolled seizure disorder;
14. other neurological conditions such as multiple sclerosis or Parkinson's Disease;
15. pain that is scored greater than 5 out of 10 on a visual analog scale;
16. any factor contraindicative to MRI examination (e.g., cardiac pacemaker/ defibrillator, pregnancy, aneurysm clips, insulin pump, metal fragments in the body).
17. any other health problems judged by their screening physician to put the client at significant risk of harm during the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
U.S. Army Medical Research and Development Command
FED
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stacy Fritz, Ph.D., P.T.
Role: PRINCIPAL_INVESTIGATOR
University of South Carolina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
921 Assembly Street, 3rd Floor, Public Health Research Center, University of South Carolina
Columbia, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00007596
Identifier Type: OTHER
Identifier Source: secondary_id
INTRuST-Walking and Balance
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.